Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States.

ABSTRACT:

Importance

Pharmacist-led interventions can significantly improve blood pressure (BP) control. The long-term cost-effectiveness of pharmacist-prescribing interventions implemented on a large scale in the US remains unclear.

Objective

To estimate the cost-effectiveness of implementing a pharmacist-prescribing intervention to improve BP control in the US.

Design, setting, and participants

This economic evaluation included a 5-state Markov model based on the pharmacist-prescribing intervention used in The Alberta Clinical Trial in Optimizing Hypertension (or RxACTION) (2009 to 2013). In the trial, control group patients received an active intervention, including a BP wallet card, education, and usual care. Data were analyzed from January to June 2023.

Main outcomes an

SUBMITTER: Dixon DL 

PROVIDER: S-EPMC10625044 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature